Journal article
Glucagon-like peptide-1 receptor agonists and heart failure in type 2 diabetes: systematic review and meta-analysis of randomized and observational studies
Abstract
BackgroundThe effect of glucagon-like peptide-1(GLP-1) receptor agonists on heart failure remains uncertain. We therefore conducted a systematic review to assess the possible impact of GLP-1 agonists on heart failure or hospitalization for heart failure in patients with type 2 diabetes.MethodsWe searched MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials (CENTRAL) and ClinicalTrials.gov to identify randomized controlled trials …
Authors
Li L; Li S; Liu J; Deng K; Busse JW; Vandvik PO; Wong E; Sohani ZN; Bala MM; Rios LP
Journal
BMC Cardiovascular Disorders, Vol. 16, No. 1,
Publisher
Springer Nature
Publication Date
December 2016
DOI
10.1186/s12872-016-0260-0
ISSN
1471-2261
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AnimalsChi-Square DistributionDiabetes Mellitus, Type 2Glucagon-Like Peptide-1 ReceptorHeart FailureHospitalizationHumansHypoglycemic AgentsObservational Studies as TopicOdds RatioRandomized Controlled Trials as TopicRisk AssessmentRisk FactorsTime FactorsTreatment OutcomeGlucagon-Like Peptide-1 Receptor Agonists